CYP2A6 and lung cancer: Further support for a direct effect can be found from studies, where after controlling for cigarette consumption (cigarettes per day and/or cigarette pack-years), CYP2A6 genotype reduced metabolizers, relative to normal metabolizers, continue to exhibit a decreased risk of having lung cancer [110,134].